Fundraising Fox

Mytide Therapeutics

Boston, US · Founded 2017 · Delaware corporation

Biotech

Founders & leadership

Mytide Therapeutics was founded in 2017 by Dale Thomas.

DT
Dale ThomasMr. Thomas is the President of the Issuer.
JN
Jason NorrisMr. Norris is the Treasurer and Secretary of the Issuer.
EA
Errik AndersonNamed on SEC filing

Reported raises · per SEC filings

Form D private placements

$8.2M disclosed across 2 rounds · 2021–2022

▶$1.2MraisedJan 2023 · 9 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Errik AndersonDirector
  • Jason NorrisExecutive Officer, Director, Promoter
  • Dale ThomasExecutive Officer, Director, Promoter
Offering amount
$2.5M
Amount sold
$1.2M
First sale
Dec 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$7.1MraisedJun 2022 · 23 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Jason NorrisExecutive Officer, Director, Promoter
  • Errik AndersonDirector
  • Dale ThomasExecutive Officer, Director, Promoter
Offering amount
$7.1M
Amount sold
$7.1M
First sale
Dec 2021
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Non-dilutive funding · 1 SBIR/STTR award

Federal grants — no equity taken
AgencyPhaseYearAmount
National Science FoundationPhase I2020$225K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

Frequently asked questions

Who founded Mytide Therapeutics?
Mytide Therapeutics was founded by Dale Thomas in 2017.
How much funding has Mytide Therapeutics raised?
Mytide Therapeutics has disclosed $8.2M raised across 2 rounds.
Where is Mytide Therapeutics headquartered?
Mytide Therapeutics is headquartered in Boston, US.